This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Clinical Outcome of Pediatric Dermatofibrosarcoma Protuberans

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2005 by National Taiwan University Hospital.
Recruitment status was:  Recruiting
Information provided by:
National Taiwan University Hospital Identifier:
First received: September 12, 2005
Last updated: November 23, 2005
Last verified: August 2005
Retrospective review of clinical outcome of pediatric Dermatofibrosarcoma Protuberans (PDFSP) after active invitation

Soft Tissue Neoplasms

Study Type: Observational
Study Design: Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Retrospective
Official Title: Retrospective Clinical Outcome Study of Pediatric Dermatofibrosarcoma Protuberans: Single Institutional Experience of Twelve Cases From 1977-2002

Resource links provided by NLM:

Further study details as provided by National Taiwan University Hospital:

Estimated Enrollment: 12
Study Start Date: June 2005
Estimated Study Completion Date: August 2005
Detailed Description:
Soft tissue sarcoma was rarely seen in pediatric patients, and pediatric Dermatofibrosarcoma Protuberans (PDFSP) was even rare. To our knowledge, the largest report constituted of 19 cases (five of them had no follow-up (FU) status) (1). So we proposed this retrospective study based on the cancer registry of our hospital. Twelve cases who were diagnosed as DFSP before age of 18 were identified. But all of them had been lost of FU for at least two years. So we will try to contact these patients and asked them to be back to our clinic for routine surveillance (history taking and physical exam and optional local image/chest xray) and quality of life (QoL) evaluation after pathological review if this clinical study was approved (2)

Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients diagnosed as DFSP before age of 18 after pathological review according to the cancer registry of our hospital

Exclusion Criteria:

  • age > 18 at diagnosis
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00173355

Contact: Chun-Ru Chien, M.D. 886-2-23123456 ext 2643
Contact: Rong-Sen Yang, M.D, Ph.D 886-2-23516478 ext 3958

National Taiwan University Hospital Recruiting
Taipei, Taiwan, 100
Contact: Rong-Sen Yang, MD, PhD    886-23123456 ext 3958   
Contact: Chun-Ru Chien, M.D.    886-2-23516478 ext 2643   
Principal Investigator: Rong-Sen Yang, MD, PhD         
Sponsors and Collaborators
National Taiwan University Hospital
Study Chair: Rong-Sen Yang, M.D., Ph.D. National Taiwan University Hospital
  More Information Identifier: NCT00173355     History of Changes
Other Study ID Numbers: 9461700618
Study First Received: September 12, 2005
Last Updated: November 23, 2005

Keywords provided by National Taiwan University Hospital:
pediatric Dermatofibrosarcoma Protuberans

Additional relevant MeSH terms:
Soft Tissue Neoplasms
Neoplasms, Fibrous Tissue
Neoplasms, Connective Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms by Histologic Type
Neoplasms by Site processed this record on September 19, 2017